| ID # | Required D/P's | Enrolled D/P's | Remaining D/P's | Inclusion Criteria |
|---|---|---|---|---|
| 53446 | 20 | 20 | 0 | Samples for Chikunkunya Validation |
| 53295 | 16 | 16 | 0 | Pre-Selected HBV Chronic and Acute Samples from Inventory |
| 53256 | 35 | 35 | 0 | Pre-Selected HBV ay Samples from Inventory |
| 53095 | 35 | 35 | 0 | Pre-Selected HBeAg and anti-HBe Samples from Inventory |
| 52791 | 47 | 47 | 0 | Pre-Selected HBV Samples from Inventory |
| 52663 | 6 | 6 | 0 | Pre-Selected Anti-HBcore Units from Inventory |
| 52393 | 103 | 103 | 0 | Pre-Selected HBsAg Samples from Inventory |
| 52285 | 10 | 10 | 0 | Pre-Selected anti-HCV Positive/Reactive Samples from Inventory |
| 52189 | 10 | 10 | 0 | Pre-Selected Anti-HBcore Samples from Inventory with Unit BackUps |
| 51890 | 81 | 81 | 0 | Pre-Selected anti-HBs Samples from Inventory |
| 51889 | 130 | 130 | 0 | Pre-Selected anti-HAV Total Samples from Inventory |
| 51756 | 110 | 110 | 0 | Pre-Selected HIV Serum Samples from Inventory |
| 51725 | 63 | 63 | 0 | Pre-Selected HIV Samples from Inventory with Viral Load |
| 51585 | 29 | 29 | 0 | Pre-Selected HBsAg Positive/Reactive Samples from Inventory |
| 51584 | 31 | 31 | 0 | Pre-Selected Anti-HCV Positive Samples from Inventory |
| 51583 | 31 | 31 | 0 | Pre-Selected Anti-HBcore Total Samples from Inventory |
| 51531 | 1 | 1 | 0 | Pre-Selected HAV IgM Samples from Inventory |
| 50347 | 254 | 253 | 1 | Pre-Selected HCV Positive Samples with Viral Load and Genotype from Inventory |
| 49245 | 13 | 13 | 0 | Pre-Selected Hepatitis Be Antigen Samples from Inventory |
| 49244 | 7 | 7 | 0 | Pre-Selected anti-HBcore IgM Samples from Inventory |
| 49226 | 100 | 100 | 0 | HIV Positive Samples from Inventory |
| 49225 | 11 | 11 | 0 | HBV Matched Sets Selection from Inventory |
| 49222 | 3 | 3 | 0 | Pre-Selected HBV Samples for Evaluation |
| 49078 | 1 | 1 | 0 | Pooled Urine Material |
| 49076 | 137 | 137 | 0 | Pre-Selected RPR Samples from Inventory |
| 49049 | 8 | 11 | -3 | HIV Positive Blood Collection Protocol |
| 48897 | 322 | 322 | 0 | Multi-Analyte Sample Selection for Anti-HAV IgM, HIV, HBsAg, HBcore Total, HBcore IgM, HBeAg and anti-HCV |
| 48563 | 7 | 7 | 0 | Pre-Selected HIV Group and Subtyped Samples from Inventory |
| 48390 | 205 | 205 | 0 | Pre-Selected HIV Positive Serum Samples from Inventory |
| 48271 | 16 | 33 | -17 | HgbA1C Multiple Matrix Blood Collection Protocol |
| 48140 | 50 | 50 | 0 | Residual Insulin Samples |
| 47934 | 2 | 2 | 0 | Pre-Selected High Risk samples from Inventory |
| 47732 | 10 | 13 | -3 | HIV Positive Matched Set Blood Collection Protocol |
| 47659 | 50 | 30 | 20 | Pre-Selected HIV Reactive and Non-Reactive Serum Samples from Inventory |
| 47615 | 10 | 10 | 0 | Pre-Selected HIV Ag/Ab Negative Serum Samples from Inventory |
| 47614 | 40 | 40 | 0 | Pre-Selected Anti-HBe Negative Samples from Inventory |
| 47427 | 40 | 40 | 0 | Pre-Selected HIV-1 and HIV-2 Serum Samples from Inventory |
| 47419 | 25 | 26 | -1 | Normal Matched DP Time Stability Blood Collection Protocol |
| 47221 | 250 | 250 | 0 | Pre-Selected HBsAg Samples form Inventory |
| 47184 | 5 | 5 | 0 | HIV Positive Matched Set Blood Collection Protocol |
| 47158 | 1 | 1 | 0 | Pre-Selected HCV Positive Sample from Inventory |
| 47114 | 8 | 8 | 0 | Pre-Selected Elevated HCV Viral Load Samples from Inventory (SFE's) |
| 46966 | 2 | 2 | 0 | Pre-Selected HBV Elevated Viral Load Samples from Inventory |
| 45752 | 8 | 8 | 0 | Pre-Selected Elevated HCV Viral Load Samples from Inventory |
| 45711 | 101 | 101 | 0 | Pre-Selected HBV Genotype B Samples from Inventory |
| 45688 | 20 | 30 | -10 | HIV Positive Matched Set Blood Collection Protocol |
| 45472 | 31 | 0 | 31 | Pre-Selected HCV Samples from Inventory |
| 45471 | 77 | 0 | 77 | Pre-Selected HBsAg Samples from Inventory |
| 45427 | 30 | 30 | 0 | Pre-Selected Anti-HBe and HBeAg Samples from Inventory |
| 45426 | 3 | 3 | 0 | Pre-Selected HBV Positive Samples with Elevated Viral Loads |
| 45194 | 50 | 50 | 0 | Pre-Selected HBV Genotype A Samples from Inventory |
| 45180 | 12 | 12 | 0 | Pre-Selected anti-HBs Positive Samples from Inventory |
| 45156 | 3 | 3 | 0 | Pre-Selected HIV Samples from Inventory |
| 44140 | 30 | 23 | 7 | Normal DP Time Stability Blood Collection Protocol |
| 44094 | 8 | 8 | 0 | Pre-Selected HIV-1 and HIV-2 SFE's |
| 43941 | 153 | 153 | 0 | Pre-Selected Anti-HBs Samples from Inventory |
| 43910 | 78 | 84 | -6 | Normal DP Time Stability Blood Collection Protocol |
| 43904 | 75 | 75 | 0 | HCV Positive Matched Set Blood Collection Protocol with a Negative Control Set |
| 43903 | 2 | 2 | 0 | Pre-selected HCV Genotyped samples from Inventory |
| 42815 | 1 | 1 | 0 | Pre-Selected HBV Genotype A Samples from Inventory |
| 42749 | 4000 | 4014 | -14 | Negative/Normal Serum specimens |
| 42721 | 197 | 197 | 0 | Pre-Selcted HBsAg Serum Samples from Inventory |
| 42610 | 3 | 3 | 0 | Pre-Selected HCV Samples form Inventory |
| 42320 | 2000 | 140 | 1860 | Prospective Vaginal Swab & Urine Collection Protocol |
| 42272 | 1 | 1 | 0 | Pre-Selected HCV Genotype 4 Samples from Inventory |
| 42227 | 3 | 1 | 2 | Pre-Selected HBV Samples from Inventory |
| 42187 | 27 | 27 | 0 | Pre-Selected HBV Positive Samples with Elevated Viral Loads with Unit Back-Ups |
| 42054 | 2000 | 2000 | 0 | Negative/Normal Serum and Plasma specimens |
| 41986 | 20 | 18 | 2 | HIV Positive Matched Set Blood Collection Protocol |
| 41913 | 73 | 73 | 0 | Pre-Selected Chagas Samples from Brazil and Bolivia |
| 41891 | 20 | 22 | -2 | Matched HIV Prospective Blood Collection Protocol with a DBS Set |
| 41724 | 20 | 0 | 20 | HIV-2 Test Comparison Study with a Blood Collection Paired Set |
| 41429 | 100 | 100 | 0 | Pre-Selected HIV Samples from Inventory Unique DPs with HIV-1 Viral Load of => 10000 IU/mL (8700 cp/mL) and volume =>2.1 mL's Matrix: EDTA, ACD & CPDA-1 |
| 41164 | 13 | 13 | 0 | Pre-Selected HBV Samples from Inventory |
| 41064 | 10 | 10 | 0 | HIV & HCV Matched Sets |
| 40988 | 81 | 81 | 0 | HIV, HBV and HCV Performance Panels |
| 40862 | 9 | 9 | 0 | Pre-selected HCV samples from inventory with specific titers and Genotypes (3 with 1a; 4 with 2a; 3 with 2b; 1 with 6) |
| 40861 | 11 | 11 | 0 | Pre-selected HBV samples from inventory with specific titers and Genotype (6 with GT B; 3 with GT E; and 2 with GT F) |
| 40860 | 40 | 40 | 0 | Pre-Selected HIV Samples from Inventory Unique DPs with HIV-1 Viral Load of => 10000 IU/mL (8700 cp/mL) and volume =>2.1 mL's Matrix: EDTA, ACD & CPDA-1 |
| 40765 | 500 | 472 | 28 | Pre-Selected HCV Samples from Inventory |
| 40764 | 150 | 44 | 106 | Pre-Selected HBV Samples from Inventory - HBV Viral Load of => 1,000 IU/mL - Singly infected - Volume of: 100 @ =>2.1 mL & 50 @ =>3.0 mL - Matrix: EDTA, ACD & CPDA-1 |
| 40762 | 600 | 485 | 115 | Pre-Selected HIV Samples from Inventory Unique DPs with HIV-1 Viral Load of => 15000 IU/mL (8700 cp/mL) and volume of 550 @ =>2.1 mL & 50 @ =>3.0 mL Matrix: EDTA, ACD & CPDA-1 |
| 40546 | 5 | 5 | 0 | HIV Positive Multiple Marix S-Monovete Collection |
| 40355 | 69 | 69 | 0 | Frozen Normal Human K2 EDTA Plasma from Unique DPs |
| 40292 | 20 | 22 | -2 | HIV Positive Blood Collection Protocol |
| 40239 | 170 | 0 | 170 | HCV Positive Blood Collection Protocol |
| 40157 | 1 | 1 | 0 | Pre-Selected HBV Genotype A Sample from Inventory with a Viral Load > 100,000,000 IU/mL |
| 38984 | 40 | 39 | 1 | Matched HIV Prospective Blood Collection Protocol with a DBS Set |
| 38975 | 300 | 300 | 0 | Pre-Selected HCV Samples from Inventory |
| 38974 | 97 | 97 | 0 | Pre-Selected HBV Samples from Inventory |
| 38973 | 400 | 400 | 0 | Pre-Selected HIV Samples from Inventory |
| 38972 | 6 | 7 | -1 | K3EDTA, ACD & Sodium Citrate Plasma Bulk Units |
| 38969 | 20 | 22 | -2 | Negative / Non-Reactive Matched Sets of PPT and EDTA Plasma |
| 38729 | 6 | 6 | 0 | Healthy and Unhealthy Sodium Heparin Blood Collection Protocol |
| 38609 | 311 | 311 | 0 | HIV, HCV and HBsAg Selections for Global Surveillance |
| 38552 | 8 | 8 | 0 | Pre-Selected HCV Positive Samples from Inventory |
| 38542 | 4 | 4 | 0 | Pre-Selected HAV IgM Samples from Inventory |
| 38424 | 33 | 31 | 2 | Pre-Selected HBV positive Samples from Inventory |
| 38368 | 1 | 1 | 0 | Pre-Selected HAV IgM from Inventory |
| 37807 | 63 | 59 | 4 | HIV Positive Multiple Marix S-Monovete Collection |
| 37765 | 10 | 10 | 0 | Pre-Selected HIV Serum Samples from Inventory |
| 37726 | 100 | 98 | 2 | Pre-Selected HIV Positive Serum Samples from Inventory |
| 37691 | 3 | 3 | 0 | Pre-Selected HBsAg Units from Sample Back-Ups |
| 37478 | 200 | 200 | 0 | Pre-Selected HIV Positive Samples with Viral Load and Goup/Subtype |
| 36104 | 30 | 30 | 0 | Pre-Selected Anti-HBcore Positive Matched Samples with Anti-HBe, HBeAg and Anti-HBs Testing |
| 36082 | 19 | 19 | 0 | Matched Sets Seruma and Plasma - HBsAg Positive/Reactive Samples |
| 36081 | 26 | 26 | 0 | HBsAg Reactive Samples with Unit Back-Ups |
| 35976 | 21 | 21 | 0 | Pre-Selected Anti-HBcore / Anti-HBs Samples from Inventory |
| 35904 | 750 | 626 | 124 | Evaluation of the Clinical Utility of the cobas® MRSA/SA Test for Detection of Staphylococcus aureus and Methicillin Resistant Staphylococcus aureus From Nasal Swabs |
| 34499 | 20 | 20 | 0 | HIV-1 Positive / Reactive Samples from Inventory |
| 33908 | 80 | 80 | 0 | Matched HIV Prospective Blood Collection Protocol with a DBS Set |
| 33907 | 50 | 48 | 2 | HIV Positive Blood Collection Protocol |
| 33324 | 60 | 60 | 0 | Texas Resident Random DP Time Stability Blood Collection Protocol |
| 33107 | 12 | 12 | 0 | Anti-HBs NR and HBsAg R Matched Selections from Inventory |
| 33084 | 3 | 3 | 0 | Pre-Selected HIV-2 Samples from Inventory |
| 33007 | 1000 | 1008 | -8 | Prospective Normal/ Negative Sample Request |
| 32903 | 800 | 800 | 0 | Normal/ Negative Multiple Matrix Sample Request |
| 32759 | 2 | 2 | 0 | Preselected samples from inventory: HBV with GT E result |
| 32398 | 63 | 63 | 0 | Pre-Selected HBV Positive Samples |
| 32227 | 6 | 6 | 0 | Pre-Selected HBV Genotype C Samples from Inventory |
| 32034 | 5 | 0 | 5 | Pre-Selected HCV Genotypes 4, 5 and 6 Samples from Inventory |
| 32003 | 14 | 14 | 0 | Pre-Selected Back-Up Units from JRId#31409 |
| 31900 | 1 | 1 | 0 | Pre-Selected HCV Genotype 6 from Inventory |
| 31856 | 320 | 210 | 110 | Pregnant HIV High Risk Blood Collection Protocol |
| 31793 | 124 | 124 | 0 | Pediatric HIV High Risk Blood Collection Protocol |
| 31651 | 56 | 56 | 0 | Pre-Selected HCV Genotype Samples from Inventory |
| 31613 | 7 | 7 | 0 | Pre-Selected HCV Positive Samples from Inventory |
| 31602 | 9 | 9 | 0 | Pre-Selected Samples from Evaluation with Low S/CO Ratios for Anti-HIV 1/2 and Anti-HCV |
| 31540 | 3 | 3 | 0 | Pre-Selected HCV Samples from Inventory |
| 31505 | 45 | 45 | 0 | Random Local DP Time Stability Blood Collection Protocol |
| 31409 | 6000 | 3875 | 2125 | Normal Plasma with Unit Back-Ups |
| 31216 | 10 | 10 | 0 | HIV Positive Blood Collection Protocol |
| 31045 | 25 | 28 | -3 | Matched Negative Prospective Blood Collection Protocol |
| 31016 | 101 | 102 | -1 | Normal Multiple Matrix Blood Collection Protocol |
| 30778 | 5 | 5 | 0 | Pre-Selected HBsAg Samples from Inventory |
| 30624 | 10 | 10 | 0 | Pre-Selected HIV Positive Samples from Inventory with Titer |
| 30390 | 32 | 32 | 0 | Pre-Selected HBV Material in Inventory |
| 30364 | 2 | 2 | 0 | Pre-Selected HCV Positive Samples from Inventory |
| 30222 | 25 | 25 | 0 | Pre-Selected HBV Samples from Inventory |
| 30125 | 3 | 3 | 0 | Pre-selected HBsAg Samples from Inventory |
| 30066 | 1 | 1 | 0 | HBV Sample for Evaluation with Back-Ups |
| 30020 | 8 | 8 | 0 | Low HIV-1 Viral Load Samples |
| 29844 | 400 | 309 | 91 | Normal / Negative Samples Selected from Inventory |
| 29768 | 500 | 508 | -8 | Normal CPD Plasma Samples with unit Back-Ups |
| 29647 | 7 | 7 | 0 | Pre-Selected HBV Samples from Inventory |
| 29622 | 6 | 6 | 0 | Negative Plasmapherese Units |
| 29538 | 81 | 81 | 0 | Pre-Selected HBsAg Samples form Inventory |
| 29537 | 2 | 2 | 0 | Pre-Selected HBV Positive Samples from Inventory |
| 29472 | 30 | 30 | 0 | Panel Members for Anti-HBs, HIV Ag/Ab & HBsAg (10 each) |
| 29465 | 20 | 20 | 0 | Negative / Normal Human Serum |
| 29285 | 63 | 63 | 0 | Pre-Selected HIV-2 Samples from Inventory |
| 29252 | 30 | 30 | 0 | Pre-Selected HIV-2 Samples from Inventory |
| 28914 | 5 | 5 | 0 | Pre-Selected HBV Samples from Inventory |
| 28888 | 70 | 70 | 0 | HIV Positive Blood Collection Protocol - African Origin D/Ps - HIV-1 viral load >=529 cp/mL - 20 mL - NAT singly infected - Unique DPs |
| 28819 | 57 | 105 | -48 | HIV Blood Collection Protocol |
| 28796 | 4 | 4 | 0 | Multiple Matrix High Volume Negative Material |
| 28765 | 36 | 36 | 0 | Pre-Selected Syphillis Samples form Inventory |
| 28762 | 45 | 5 | 40 | Pre-Selected HBV High Titer Material |
| 28730 | 3 | 3 | 0 | Pre-Selected HIV Positive D/Ps |
| 28722 | 50 | 40 | 10 | HIV Positive Stability Study |
| 28693 | 93 | 93 | 0 | HIV Positive Blood Collection Protocol - African Origin D/Ps - HIV-1 viral load >=529 cp/mL - 20 mL - NAT singly infected - Unique DPs |
| 28692 | 86 | 86 | 0 | HIV Positive Blood Collection Protocol - Continental US only - HIV-1 viral load >=529 cp/mL - 20 mL - NAT singly infected - Unique DPs |
| 28598 | 5 | 3 | 2 | Pre-Selected Anti-HAV Samples in Inventory |
| 28488 | 3 | 3 | 0 | Pre-Selected HBV Samples from Inventory |
| 28441 | 59 | 58 | 1 | HIV Positive Blood Collection Protocol |
| 28364 | 2 | 2 | 0 | Pre-Selected HBV Samples from Inventory |
| 28291 | 3 | 3 | 0 | Pre-Selected HBV Samples from Inventory |
| 28254 | 9 | 9 | 0 | Pre-Selected HCV Samples from Inventory |
| 28138 | 52 | 52 | 0 | Pre-Selected HCV Samples from Inventory |
| 27868 | 140 | 195 | -55 | Normal Multiple Matrix Blood Collection Protocol |
| 27837 | 50 | 40 | 10 | Random DP Time Stability Blood Collection Protocol |
| 27643 | 27 | 27 | 0 | Pre-Selected HCV Positive Samples from Inventory |
| 27602 | 1 | 1 | 0 | Pre-Selected HIV Positive Unit form Inventory |
| 27489 | 12 | 12 | 0 | HIV-2 Pre-Shipment Samples with Unit Back-Ups |
| 27487 | 4 | 4 | 0 | Pre-Selected HIV-2 Samples from Inventory |
| 27301 | 40 | 40 | 0 | Matched HIV Prospective Blood Collection Protocol with a DBS Set |
| 27300 | 60 | 61 | -1 | Pediatric HIV Prospective DBS Collection Protocol |
| 27283 | 28 | 28 | 0 | Pre-Selected HIV-2 Samples in Inventry with Back-Up Material |
| 27217 | 5 | 5 | 0 | Pre-Selected HIV Positive / CD4 Defined DPs |
| 26914 | 10 | 10 | 0 | Pre-Selected HAV IgG Samples from Inventory |
| 26859 | 55 | 62 | -7 | Matched HIV Prospective Blood Collection Protocol |
| 26703 | 31 | 31 | 0 | Pre-Selected HCV Positive Samples form Inventory with Viral Load and Genotype |
| 26576 | 3 | 3 | 0 | Pre-Selected HCV Genotyped Material from Inventory |
| 26548 | 18 | 18 | 0 | Pre-Selected Anti-HAV, Anti-HCV, Anti-HBcore , HAV IgM and Hepatitis Be Antigen Samples from Inventory |
| 26510 | 8 | 8 | 0 | Pre-Selected HBV Samples from Inventory |
| 26273 | 4 | 4 | 0 | Multiple Matrix High Volume Negative Material |
| 26110 | 9 | 9 | 0 | HIV pre-selected samples from inventory |
| 26107 | 24 | 24 | 0 | HCV pre-selected samples from inventory |
| 26105 | 134 | 134 | 0 | HBV pre-selected samples from inventory |
| 26010 | 37 | 37 | 0 | Pre-Selected HIV Positive Samples from Inventory |
| 25976 | 113 | 113 | 0 | HIV Positive Stability Blood Collection Protocol |
| 25975 | 1 | 1 | 0 | Pre-Selected HBV Genotype D |
| 25935 | 50 | 51 | -1 | Random DP Time Stability Blood Collection Protocol |
| 25909 | 18 | 18 | 0 | Pre-Selected HCV Samples from Inventory |
| 25856 | 9 | 9 | 0 | Pre-Selected HBV Clinical Patient Samples from Inventory |
| 25855 | 12 | 12 | 0 | Chlamydia Mirrored Samples Selected from Inventory |
| 25854 | 10 | 10 | 0 | Gonorrhea Mirrored Samples Selected from Inventory |
| 25853 | 10 | 10 | 0 | Chlamydia Mirrored Samples Selected from Inventory |
| 25663 | 40 | 45 | -5 | HIV Positive CD4 Blood Collection Protocol |
| 25552 | 150 | 150 | 0 | Pre-Selected HCV Samples with Viral Load and Genotype from Inventory |
| 25551 | 86 | 86 | 0 | Pre-Selected HBV Samples with Viral Load and Genotype from Inventory |
| 25478 | 20 | 58 | -38 | HgbA1C Multiple Matrix Blood Collection Protocol |
| 25414 | 206 | 206 | 0 | Pre-Selected HIV Positive Material from Inventory |
| 25303 | 50 | 59 | -9 | Normal Multiple Matrix Blood Collection Protocol |
| 25268 | 10 | 14 | -4 | Fresh PBMC's from HCV Positive D/Ps (Donor/Participants) |
| 25207 | 11 | 11 | 0 | HTLV I/II Samples for Evaluation |
| 25145 | 359 | 359 | 0 | Disease State Sample including: - Chags Positive Samples - Anti-HCV Samples - Anti-HIV 1/2 Samples - HBsAg Samples - Anti-HBs Samples - Rheumatoid Factor Samples - ANA Positive Samples - Toxoplasmosis Plasma Samples (IgG) - Syphilis (RPR) Samples |
| 25106 | 30 | 30 | 0 | Pre-Selected Syphillis Samples from Inventory |
| 25036 | 27 | 27 | 0 | Pre-Selected Sodium Citrate Units |
| 25009 | 40 | 40 | 0 | Pre-Selected HBeAg Positive Samples from Inventory |
| 24945 | 21 | 21 | 0 | Pre-Selected Samples from Inventory |
| 24921 | 1 | 1 | 0 | Pre-Selected HBV Samples from Inventory |
| 24890 | 4 | 4 | 0 | Pre-Selected Anti-HBcore Samples from Inventory |
| 24784 | 6 | 6 | 0 | HIV Positive, singly infected Serum samples with HIV Viral Load >= 20 and <=60 cp/ml |
| 24528 | 0 | 0 | 0 | Pre-selected HIV Positive Pediatric Samples from Inventory |
| 24510 | 11 | 11 | 0 | HIV Subtype Panel |
| 24509 | 11 | 11 | 0 | HIV Subtype Panel |
| 24478 | 1 | 1 | 0 | Pre-Selected HBeAg Samples from Inventory |
| 24474 | 29 | 29 | 0 | Pre-Selected HIV-2 Samples from Inventory |
| 24264 | 100 | 100 | 0 | Pre-Selected Serum Samples from Vietnamese D/Ps (Donor/Participants) |
| 24211 | 500 | 365 | 135 | Sexual Health of Performers Study (SHoPs) - CT/GC Collection & Testing Protocol |
| 24051 | 30 | 30 | 0 | SFE's with unit Back-Ups |
| 23766 | 169 | 169 | 0 | Pre-Selected Anti-HBcore Samples from Inventory |
| 23597 | 30 | 6 | 24 | HCV Genotype 6 Specific Prospective Blood Collection Protocol |
| 23339 | 79 | 78 | 1 | Pre-Selected HCV Samples from Inventory |
| 23033 | 25 | 25 | 0 | HAV IgG Positive Samples from Inventory |
| 22981 | 1 | 1 | 0 | HIV-2 Positive Sample |
| 22739 | 10 | 10 | 0 | Pre-Selected HAV Positive Material from Inventory |
| 22700 | 1 | 1 | 0 | Pre-Selected HCV Genotype 4 Sample from Inventory |
| 22402 | 58 | 58 | 0 | Pre-Selected HCV Samples from Inventory |
| 22401 | 50 | 50 | 0 | Pre-Selected HBV Samples from Inventory |
| 22280 | 50 | 50 | 0 | HBs Confirmatory Samples Selected form Inventory |
| 22078 | 1 | 1 | 0 | Pre-Selected HBV Samples form Inventory |
| 21806 | 43 | 43 | 0 | Pre-Selected HBV Samples from Inventory |
| 21721 | 198 | 198 | 0 | HIV Non-B Subtype Samples |
| 21107 | 200 | 200 | 0 | Anti-HBcore Positive Samples |
| 20940 | 15 | 15 | 0 | Negative/Normal Blood Collection Protocol |
| 20868 | 4 | 4 | 0 | K2EDTA Sero-Negative Plasma |
| 20786 | 1 | 1 | 0 | HIV-2 Positive sample |
| 20711 | 13 | 13 | 0 | Pre-Selected HBV Samples from Inventory |
| 20645 | 1 | 1 | 0 | HIV Ag (p24) Positive Sample |
| 20644 | 40 | 34 | 6 | CMV IgG Negative Samples |
| 20530 | 46 | 46 | 0 | Pre-Selected HIV Positive Samples from Inventory |
| 20483 | 37 | 37 | 0 | Pre-Selected HIV Positive Non-B Samples from Inventory |
| 20402 | 65 | 65 | 0 | Pre-Selected HBsAg Samples in Inventory |
| 20401 | 14 | 14 | 0 | Pre-Selected HBV Samples from Inventory |
| 20108 | 1 | 1 | 0 | Pre-Selected HBV Samples from Inventory |
| 19978 | 4 | 4 | 0 | Multiple Matrix High Volume Negative Material |
| 19903 | 81 | 81 | 0 | Pre-Selected HCV Samples from Inventory |
| 19750 | 200 | 51 | 149 | HCV Genotype 5 Specific Prospective Blood Collection Protocol |
| 19713 | 2 | 2 | 0 | Pre-Selected Elevated HBV Viral Load Samples from Inventory |
| 19572 | 19 | 1 | 18 | Pre-Selected HBV Samples from Inventory |
| 19502 | 114 | 114 | 0 | Pre-Selected HCV Positive Samples form Inventory |
| 19430 | 6 | 6 | 0 | Pre-Selected HBV Samples from Inventory |
| 19107 | 35 | 35 | 0 | Pre-Selected HBV Samples from Inventorty |
| 19096 | 71 | 71 | 0 | Pre-Selected HBV Smples from Inventory |
| 19085 | 56 | 56 | 0 | Pre-Selected HCV+ Samples from Inventory |
| 19084 | 19 | 19 | 0 | Pre-Selected HBV+ Samples from Inventory |
| 19083 | 71 | 71 | 0 | Pre-Selected HIV+ Samples from Inventory |
| 19038 | 68 | 68 | 0 | Pre-Selected HCV Positive Samples from Inventory |
| 18988 | 2361 | 776 | 1585 | Normal DPs |
| 18245 | 101 | 101 | 0 | Fresh Frozen Plamsa Units Positive for Multiple Markers |
| 18061 | 90 | 75 | 15 | HIV High Risk Pregnant Women Blood Collection Protocol |
| 17976 | 1 | 1 | 0 | Pre-Selected HBV Sample from Inventory |
| 17974 | 2 | 2 | 0 | Pre-Selected HIV Positive Units from Inventory |
| 17442 | 27 | 27 | 0 | Pre-Selected HCV Positive Samples form Inventory |
| 17441 | 500 | 404 | 96 | Sero-Negative Prospective Blood Collection Protocol |
| 17225 | 14 | 14 | 0 | Pre-Selected HBV Samples from Inventory |
| 17100 | 26 | 26 | 0 | Pre-Selected HIV Positive SFE's with Unit Back-Ups |
| 16633 | 10 | 10 | 0 | Pre-Selected anti-HBs & HBcore Samples from Inventory |
| 16460 | 2 | 2 | 0 | Plasma, Human, HIV-1 Ab Positive, Western Blot Selected DP's |
| 16334 | 1 | 1 | 0 | Pre-Selected anti-HBc & anti-HBs Sample for Evaluation (with Back-Up Material) |
| 16254 | 2 | 2 | 0 | HCV Positive, singly infected Serum samples with HCV GT 3, and HCV Viral Load >= 1.00E+05 IU/ml |
| 15969 | 200 | 200 | 0 | Pre-Selected HBsAg Samples from Inventory |
| 15917 | 8 | 8 | 0 | Normal Cardiac Blood Collection Protocol |
| 15877 | 5 | 5 | 0 | Plasma, Human, HIV-1 Ab Positive, Western Blot (SFE's) |
| 15832 | 439 | 439 | 0 | HIV Positive Blood Collection Protocol |
| 15759 | 26 | 26 | 0 | Pre-Selected Anti-HBe & HBeAg Samples form Inventory |
| 15690 | 35 | 41 | -6 | HIV Positive Pregnant Women Blood Collection Protocol |
| 14871 | 14 | 15 | -1 | HCV Positive Blood Collection Protocol with Special Handling |
| 14870 | 3 | 3 | 0 | Pre-Selected HBV Samples from Inventory |
| 14833 | 2 | 2 | 0 | HIV Positive, singly infected samples with specific HIV Viral Load and HIV Group O result |
| 14745 | 2 | 2 | 0 | Pre-Selected HCV Bulk Material in Stock |
| 14638 | 20 | 20 | 0 | Pre-Selected HCV Samples from Inventory - Anti-HCV Positive with Detectable Viral Load |
| 14603 | 7 | 7 | 0 | HCV Viral Load SFE's |
| 14602 | 10 | 8 | 2 | HIV-2 Samples for Evaluation with Bulk Back Up Units |
| 14241 | 10 | 10 | 0 | HIV Positive Multiple Matrix Blood Collection Protocol |
| 13981 | 10 | 10 | 0 | Pre-Selected HCV Samples from Inventory |
| 13829 | 10 | 10 | 0 | HCV Positive Samples for Genotype Testing with Back-Up Material |
| 13826 | 300 | 320 | -20 | High Risk Population Blood Collection Protocol |
| 13687 | 30 | 30 | 0 | HBV Positive, singly infected matched sets with specific HBV Viral Load and HBV Genotype results |
| 13686 | 55 | 55 | 0 | HBV Positive, singly infected matched sets with specific HBV Viral Load and HBV Genotype results |
| 13565 | 5 | 5 | 0 | Pre-Selected HCV Positive Samples with Detectable Viral Load |
| 13376 | 41 | 41 | 0 | HCV Positive, singly infected samples with specific HCV Viral Load and any HCV Genotype result |
| 13086 | 20 | 20 | 0 | Pre-Selected Anti-HAV Total Samples from Inventory |
| 13014 | 25 | 15 | 10 | HIV Positive Pediatric Blood Collection |
| 12970 | 3 | 3 | 0 | HIV-1 SFE's with Back-Up Samples |
| 12790 | 112 | 114 | -2 | HIV Low Risk Pediatric Blood Collection Protocol |
| 12788 | 96 | 96 | 0 | Pre-Selected Syphillis Samples form Inventory |
| 12627 | 12 | 12 | 0 | Pre-Selected HBV Samples form Inventory |
| 12534 | 8 | 8 | 0 | Pre-Selected HIVAg p24 Samples form Inventory |
| 12344 | 57 | 57 | 0 | Pre-Selected HIV Samples From Inventory |
| 12158 | 22 | 22 | 0 | Pre-Selected HCV Positive Samples with Viral Load and Genotype |
| 12005 | 23 | 23 | 0 | Negative/Normal Cadaveric Serum and Plasma Paired Samples |
| 11719 | 152 | 152 | 0 | Pre-Selected Early Actue, Acute, Chronic and Immune Natural Infection HBV Positive D/Ps |
| 11536 | 250 | 316 | -66 | Normal Cardiac Blood Collection Protocol |
| 10691 | 200 | 150 | 50 | Apparently Healthy Population Blood Collection Protocol |
| 10689 | 3 | 3 | 0 | Pre-Selected HIV Type O from Inventory |
| 10662 | 22 | 22 | 0 | Pre-Selected Toxoplasma IgM Samples from Inventory |
| 10609 | 3 | 3 | 0 | Pre-Selected HCV Super Elevated Viral Load Material form Inventory |
| 10506 | 6 | 6 | 0 | Pre-Selected HCV Samples from Inventory |
| 10488 | 18 | 18 | 0 | HIV SFE's with Unit Back-Ups |
| 10459 | 8 | 8 | 0 | Pre-Selected HCV Super Elevated Viral Load Samples from Inventory |
| 10375 | 60 | 60 | 0 | Pre-Selected HCV Samples form Inventory |
| 10210 | 7 | 7 | 0 | HCV Samples from Inventory |
| 10141 | 107 | 107 | 0 | HCV Samples from Invemtory |
| 10031 | 110 | 109 | 1 | HCV Positive Blood Collection Protocol with Special Handling Plan including a Negative Control Group |
| 9956 | 46 | 46 | 0 | Pre-Selected HIV Positive Samples from Inventory |
| 9952 | 70 | 70 | 0 | Vitamin D Blood Collection Protocol |
| 9311 | 250 | 233 | 17 | 2010-8192(B): Folate WHO Re-standardization Blood Collection Protocol |
| 9161 | 14 | 14 | 0 | Pre-Selected HIV Group and Subtyped Samples from Inventory |
| 9160 | 6 | 6 | 0 | Pre-Selcted HIV Group and Subtyped Material |
| 9159 | 33 | 33 | 0 | Negative Bulk EDTA Material |
| 9108 | 1 | 1 | 0 | Pre-Selected HCV Viral Load and Genotyped Bulk Unit |
| 9074 | 97 | 97 | 0 | Pre-Selected HBV Genotyped Samples form Inventory |
| 9057 | 175 | 156 | 19 | Negative / Normal Blood Collection Protocol - Paired Matrices (K3EDTA & Serum) |
| 9047 | 20 | 20 | 0 | Negative / Normal Blood Collection Protocol - Paired Matrices |
| 9028 | 80 | 80 | 0 | Pre-Selected Residual Urine Samples from Inventory |
| 9027 | 1 | 1 | 0 | Pre-Selected HCV Sample from Inventory for Evaluation - Back Up Unit Available |
| 9012 | 3 | 3 | 0 | Pre-Selected HIV-2 Samples from Inventory |
| 9009 | 22 | 22 | 0 | HBsAg Pediatric Blood Collection Protocol |
| 8989 | 2000 | 244 | 1756 | Negative / Normal Blood Collection Protocol |
| 8979 | 66 | 66 | 0 | Pre-Selected HIV Group and Subtype Material from Inventory |
| 8939 | 22 | 22 | 0 | Pre-Selected HTLV I/II Samples from Inventory |
| 8917 | 2 | 2 | 0 | HIV Group O from Inventory |
| 8838 | 151 | 151 | 0 | Pre-Selected HBcore samples form Inventory |
| 8832 | 10 | 10 | 0 | Pre-Selected HIV-2 Positive Samples from Inventory |
| 8831 | 28 | 28 | 0 | Pre-Selected HIV-2 Negative Samples from Inventory |
| 8823 | 3500 | 2068 | 1432 | Low Risk HIV Population Blood Collection Protocol |
| 8676 | 4 | 4 | 0 | Pre-Selected HIV Positive Samples from Inventory with Viral Loads at > 1MM cp/ml |
| 8652 | 50 | 50 | 0 | Pre-Selected Negative samples from Inventory |
| 8590 | 3 | 3 | 0 | HIV-1 Positive Samples with unit Back-Ups SFE's |
| 8555 | 2 | 2 | 0 | Pre-Selcted HIV-2 Samples |
| 8546 | 2 | 2 | 0 | Pre-Selected HIV-2 Samples from Inventory |
| 8520 | 13 | 3 | 10 | Pre-Selected HIV Postive Samples fom Inventory with Viral Loads at > 1MM |
| 8414 | 106 | 106 | 0 | Pre-Selected HBV Samples form Inventory |
| 8413 | 11 | 11 | 0 | Pre-Selected HCV Genotypes 2 and 3 Samples from Inventory |
| 8364 | 300 | 112 | 188 | 2010-8364: Pediatric HIV High Risk Blood Collection Protocol |
| 8360 | 2 | 2 | 0 | Pre-Selected HIV-2 Samples for Evaluation |
| 8357 | 50 | 50 | 0 | Pre-Selected HCV Samples form Inventory |
| 8354 | 125 | 379 | -254 | Pediatric and Neonatal Claim Extension – Hepatitis Assays |
| 8304 | 2 | 2 | 0 | Pre-Selected HCV Samples form Inventory |
| 8268 | 150 | 150 | 0 | Pre-Selected HBV Positive Samples from Inventory |
| 8257 | 289 | 288 | 1 | Pre-Selected HCV Positive Samples |
| 8230 | 2000 | 423 | 1577 | European HIV Positive Blood Collection Protocol |
| 8195 | 17 | 17 | 0 | Pre-Selected HIV Positive Samples from Inventory |
| 8192 | 500 | 477 | 23 | 2010-8192: Folate WHO Re-standardization Blood Collection Protocol |
| 8129 | 1 | 1 | 0 | Pre-Selected HIV-1 Sample form Inventory with Specific Viral Load |
| 8103 | 200 | 242 | -42 | 2010-8103: HIV-2 Positive Samples |
| 8092 | 517 | 517 | 0 | 2010-8092: HIV-2 Endemic Area Serum Samples |
| 8091 | 22 | 22 | 0 | Pre-Selcted HCV samples form Inventory |
| 8090 | 11 | 11 | 0 | Pre-Selectedd Anti-HBs Reactive/Non-Reactive Samples |
| 8089 | 14 | 14 | 0 | HBsAg Positive Samples for ad/ay project |
| 8048 | 22 | 22 | 0 | 2010-8048: Pre-Selected HCV Matched Pair Sets from Inventory |
| 8047 | 100 | 0 | 100 | 2010-8047: HIV Matched Positive Samples Collected in PPT and EDTA Tubes with Viral Loads at < 50 Copies/mL |
| 7981 | 14 | 14 | 0 | HBsAg Positive Units form Senegal for ad/ay project |
| 7957 | 14 | 15 | -1 | 2010-7957: Special Processing from HIV-1 Positive D/Ps with Detectable Viral Loads |
| 7902 | 2 | 2 | 0 | Pre-Selected HIV-2 Samples for Evaluation with Unit Back-Ups |
| 7876 | 310 | 323 | -13 | 2010-7876: HIV Positive Samples Collected in PPT Tubes |
| 7857 | 11 | 11 | 0 | Anti-HTLV I/II Samples for Evaluation with Unit Back-Ups |
| 7856 | 2 | 2 | 0 | High Titer RPR Reactive Samples for Evaluation |
| 7815 | 36 | 36 | 0 | Pre-Selected HCV Samples from Inventory |
| 7764 | 24 | 24 | 0 | Sample Order Id#:6 - Pre-Selected HIV Goup and Subtypes Samples form Inventory |
| 7759 | 2 | 2 | 0 | Pre-Selected HIV-2 Samples for Evaluation with Unit Back-Ups |
| 7743 | 22 | 22 | 0 | Pre-Selected HCV Sampls form Inventory - Genotype 1a/1b |
| 7712 | 89 | 89 | 0 | Pre-Selcted HCV Viral Load and Genotype Samples form Inventory |
| 7703 | 18 | 18 | 0 | 2009-7692 - HCV Bulk Unit Blood Collection Protocol for Pre-Selected Specific Genotypes |
| 7656 | 70 | 70 | 0 | Pre-Selected HIV Samples form Inventory |
| 7624 | 20 | 20 | 0 | Pre-selected HCV Genotype 1a/1b samples from Inventory |
| 7600 | 100 | 89 | 11 | HBsAg Units from Thailand |
| 7592 | 33 | 33 | 0 | Pre-Selected HBsAg Samples from Inventory |
| 7570 | 1 | 1 | 0 | Pre-selected HCV Genotype 2b Bulk from Inventory |
| 7569 | 42 | 42 | 0 | Pre-Selected HBsAg Samples in Inventory |
| 7564 | 20 | 20 | 0 | Pre-Selected Chagas Samples from Inventory |
| 7556 | 22 | 22 | 0 | Pre-Selected Anti-HTLV I/II Samples for Evaluation |
| 7551 | 12 | 12 | 0 | Pre-selected Anti-HBcore Samples |
| 7549 | 2 | 2 | 0 | Pre-Selected HCV Samples from Inventory |
| 7547 | 20 | 20 | 0 | HIV-1 Positive Samples for Evaluation |
| 7545 | 2 | 2 | 0 | HIV and HCV Pre-selected Samples from Inventory |
| 7442 | 11 | 11 | 0 | anti-HTLV positive plasma |
| 7441 | 17 | 17 | 0 | HBsAg (ay) Samples for Evaluation |
| 7234 | 2 | 2 | 0 | Pre-Selected HBsAg samples from Inventory (Subtype ay) |
| 7192 | 2000 | 176 | 1824 | HBV Blood Collection Protocol with Viral Load and Specific Genotypes |
| 7162 | 2 | 2 | 0 | Pre-Selected HCV Positive samples from Inventory |
| 7149 | 20 | 19 | 1 | HBsAg SFE's for ad/ay Project |
| 7142 | 4 | 4 | 0 | Pre-Selected HCV Genotyped Units form Inventory |
| 7052 | 200 | 2 | 198 | Evaluation of HBsAg Units for Elevated Titer and ad/ay |
| 7044 | 89 | 89 | 0 | Pre-Selected HCV Positive Samples with Viral Load and Genotype from Inventory |
| 7021 | 6 | 6 | 0 | Pre-Selected HIV Group and Subtype Samples from Inventory |
| 6967 | 1000 | 587 | 413 | A Point in Time Blood Collection Protocol in order to Build a Repository of Specimens from Donor/Participants (D/Ps) that are Diagnosed with HIV exclusively. |
| 6929 | 50 | 50 | 0 | RPR Titer Panel |
| 6903 | 1 | 1 | 0 | 5 Liters of EDTA Plasma |
| 6897 | 250 | 70 | 180 | RPR Panel Project |
| 6896 | 18 | 18 | 0 | 5 Liters of ACD Plasma |
| 6836 | 49 | 49 | 0 | Pre-Selected HIV Positive Samples Collected Outside the United States from Inventory |
| 6835 | 151 | 151 | 0 | Pre-Selected HIV Positive with Group/Subtype information collected Outside the United States from Inventory |
| 6834 | 900 | 897 | 3 | Pre-Selected HIV Positive Samples Collected in the United States from Inventory |
| 6833 | 100 | 100 | 0 | Pre-Selected HIV Positive Matched Sets (EDTA and Serum) collected in the United States from Inventory |
| 6794 | 14 | 14 | 0 | Pre-Selected HIV Genotype Samples from Inventory |
| 6787 | 10 | 0 | 10 | Plasma 25mL Bulk Units Pre-Selected from SFE Samples |
| 6785 | 10 | 0 | 10 | Whole Blood 50mL Bulk Units Pre-Selected from SFE Samples |
| 6782 | 40 | 0 | 40 | Parvo/HAV Negative SFE's for Evaluation with Donor Call Back |
| 6772 | 12 | 12 | 0 | Pre-Selected Sodium Citrate Units |
| 6659 | 1 | 1 | 0 | Positive Clinical Specimen Collection from Pre-Selected HCV Positive Donor/Participants(D/Ps)with Elevated Viral Loads |
| 6630 | 1 | 2 | -1 | SFE's for HBsAg Pre-Core Units |
| 6613 | 30 | 30 | 0 | HBV Negative D/Ps (Donor/Participants) for evaluating the effect of different blood collection tubes and sample handling conditions |
| 6594 | 171 | 171 | 0 | Pre-Selected Anti-HBcore Samples from Inventory |
| 6566 | 2500 | 236 | 2264 | HBV Positive D/Ps with different Viral Loads and Genotypes |
| 6565 | 1000 | 611 | 389 | HIV Positive D/Ps with different Viral Load, Groups and Subtypes |
| 6564 | 2500 | 314 | 2186 | HCV Positive D/Ps with different Viral Loads and Genotypes |
| 6561 | 6 | 6 | 0 | Pre-Selected HCV Serum/Plasma Pairs from inventory |
| 6557 | 3 | 3 | 0 | HIV Positive D/Ps who are p24 Negative and gp41 Positive |
| 6522 | 23 | 23 | 0 | HIV Positive Samples Collected in PPT Tubes with Undetectable Viral Loads |
| 6507 | 5 | 5 | 0 | HCV Genotype 5 Blood Collection Protocol |
| 6483 | 14 | 14 | 0 | Pre-Selected Anti-HIV 1/2 Units form Inventory |
| 6478 | 515 | 515 | 0 | HIV-2 High Risk Samples from an Endemic Area |
| 6474 | 50 | 13 | 37 | ACD, EDTA and Sodium Citrate Samples for Evaluation |
| 6419 | 348 | 348 | 0 | Pooling of Normal EDTA Material for External Customer |
| 6410 | 130 | 236 | -106 | HIV Positive & Syphilis Co-Infected D/Ps – Treponemal Confirmed |
| 6409 | 2 | 2 | 0 | Pre-Selected HBsAg Units from Inventory |
| 6396 | 69 | 69 | 0 | Pre-Selected HCV Positive Singly Infected Samples from Inventory |
| 6395 | 3 | 3 | 0 | Pre-Selected HIV-1 Positive Samples for Evaluation with Bulk Unit Back-Ups and Viral Load Data |
| 6394 | 20 | 20 | 0 | Pre-Selected HIV-1 Positive Samples for Evaluation with Bulk Unit Back-Ups |
| 6350 | 16 | 16 | 0 | HBV Smaples for Evaluation |
| 6328 | 20 | 20 | 0 | Pre-Selected HBsAg Samples form Inventory |
| 6266 | 1585 | 0 | 1585 | Negative Clinical Samples |
| 6245 | 500 | 107 | 393 | A Single-Site, Point in Time, Prospective Blood Collection Protocol in order to obtain Blood Samples from HBV Positive D/Ps (Donor/Participants). |
| 6243 | 500 | 50 | 450 | HIV Positive Samples Collected in PPT Tubes with Undetectable Viral Loads |
| 6232 | 2000 | 140 | 1860 | Paired Blood Collection Protocol from HCV Positive Donor/Participants (DPs) with Detectable Viral Loads |
| 6187 | 50 | 0 | 50 | HIV p24 Antigen Positive Samples |
| 6179 | 200 | 131 | 69 | HIV-2 Positive Serum Samples |
| 6162 | 60 | 60 | 0 | Chagas Positive Serum Samples from Bolivia |
| 6116 | 15 | 15 | 0 | HIV-STP-15U - HIV 15 Member Subtype Panel |
| 6097 | 4 | 4 | 0 | Pre-Selected anti-HBe and HBeAg units from Inventory |
| 6086 | 1 | 1 | 0 | Preselected Unit form Inventory |
| 6065 | 87 | 87 | 0 | HBV Samples for Evaluation for Anti-HBcore Project |
| 5970 | 27 | 27 | 0 | Pre-Selected HBV Units form Inventory |
| 5955 | 1 | 1 | 0 | Negative Control Material |
| 5948 | 258 | 257 | 1 | Pre Selcted CT/NG Urine Samples from Inventory |
| 5929 | 21 | 21 | 0 | HIV Positive Units from the United States |
| 5921 | 7 | 7 | 0 | CMV IgG Samples for Evaluation with Unit Back Ups |
| 5919 | 30 | 0 | 30 | A Single Site, Multi-Draw, Prospective Blood Collection and Vaccination Protocol in order to obtain Pre and Post Hepatitis B Vaccination Samples. |
| 5911 | 10 | 10 | 0 | Elevated Liver Enzymes Samples from Inventory |
| 5897 | 1 | 0 | 1 | Pre-Selected HBV Super Elevated Viral Load Unit |
| 5881 | 7 | 7 | 0 | Pre-Selected HCV Singly Infected Super Elevated Viral Load D/Ps |
| 5833 | 19 | 19 | 0 | Pre-Selected Anti-HBcore Samples for Evaluation |
| 5734 | 1 | 1 | 0 | Pre-Selcted HIV-1 (Subtype C) Sample from Inventory |
| 5725 | 1 | 1 | 0 | Normal Whole Blood |
| 5674 | 1 | 1 | 0 | Normal D/P |
| 5663 | 21 | 21 | 0 | HIV Positive D/Ps with Detectable Viral Load |
| 5635 | 1 | 1 | 0 | Pre-Selected HCV Genotype 2 Samples from Inventory |
| 5604 | 200 | 179 | 21 | Normal Specimens from Europe |
| 5603 | 125 | 125 | 0 | 2009-SIE0524 - Blood Collection Protocol in order to obtain HIV Positive Samples from D/Ps (Donor/Participants) with Detectable Viral Load |
| 5586 | 86 | 86 | 0 | Anti-HBe, HBeAg & HBV Pre-Selected Samples from Inventory |
| 5565 | 3 | 3 | 0 | Anti-HTLV I/II Positive Serum Samples |
| 5564 | 20 | 0 | 20 | Parvovirus B19 Positive Serum Samples |
| 5563 | 20 | 20 | 0 | Anti-HAV Total Serum Samples |
| 5562 | 20 | 0 | 20 | Anti-Nuclear Antibodies (ANA) Positive Serum Samples |
| 5561 | 20 | 0 | 20 | RF Factor Positive Serum Samples |
| 5560 | 20 | 0 | 20 | Elevated Liver Enzymes Serum Samples |
| 5559 | 20 | 0 | 20 | Toxoplasma IgG Positive Serum Samples |
| 5558 | 20 | 0 | 20 | RPR (Syphillis) Reactive Serum Samples |
| 5557 | 20 | 0 | 20 | Rubella IgG Positive Serum Samples |
| 5556 | 20 | 0 | 20 | Herpes Simplex Virus (HSV) Positive Serum Samples |
| 5555 | 20 | 0 | 20 | EBV Positive Serum Samples |
| 5554 | 20 | 0 | 20 | CMV IgG Positive Serum Samples |
| 5553 | 20 | 0 | 20 | Anti-HCV Positive Serum Samples |
| 5510 | 15 | 14 | 1 | Pre-Selected HAV Total Samples from Inventory |
| 5509 | 15 | 15 | 0 | Pre-Selected anti-HIV 1/2 Samples from Inventory |
| 5412 | 1 | 1 | 0 | HCV Genotype 2 Sample for SFE with backups |
| 5395 | 5 | 5 | 0 | HIV-1 p24 Positive Samples for Evaluation (SFE's) |
| 5380 | 50 | 13 | 37 | A Multi-Site, Point in Time, Blood Collection Protocol in order to Build a Repository of Specimens from Donor/Participants (D/Ps) that are Diagnosed with HIV with specific Mutations for Panel Development. |
| 5379 | 30 | 10 | 20 | Pre-Selected Source Plasma Units |
| 5334 | 5 | 5 | 0 | Pre-Selected HBV Units form Inventory |
| 5275 | 37 | 37 | 0 | HBsAg Samples for Evaluation with Bulk Material Back Up |
| 5240 | 27 | 27 | 0 | Plasmapherese SFE's Negative/Non-Reactive for: HIV/HBV/HCV/B19 |
| 5227 | 100 | 0 | 100 | Collection of blood from D/Ps with Signs and Symptoms or at High Risk for Hepatitis - Pediatric Category |
| 5226 | 77 | 77 | 0 | Collection of blood from D/Ps with Signs and Symptoms or at High Risk for Hepatitis - Pregnancy Target Category |
| 5224 | 79 | 79 | 0 | Collection of blood from D/Ps with Signs and Symptoms or at High Risk for Hepatitis - Kidney Dialysis Category |
| 5210 | 1142 | 1197 | -55 | Collection of blood from D/Ps with Signs and Symptoms or at High Risk for Hepatitis - Signs & Symptoms / High Risk Categories |
| 5192 | 11 | 11 | 0 | Pre-Selected HBV Units form Inventory |
| 5191 | 10 | 9 | 1 | Fresh EBV Positive Samples (< 2 months old) |
| 5190 | 11 | 11 | 0 | Fresh HAV Total Positive Samples (< 2 months old) |
| 5189 | 10 | 10 | 0 | Fresh CMV IgG Positive Samples (< 2 months old) |
| 5188 | 10 | 10 | 0 | Fresh HIV Positive Samples (< 2 months old) |
| 5187 | 10 | 10 | 0 | Fresh HCV Positive Samples (< 2 months old) |
| 5152 | 30 | 30 | 0 | HBV Samples for Evaluation with Unit Back Ups |
| 5048 | 100 | 14 | 86 | Anti-HCV Positive Units from the United States |
| 5047 | 100 | 10 | 90 | Anti-HTLV I/II Positive Units from the United States |
| 5046 | 100 | 28 | 72 | Anti-HBcore Positive Units from the United States |
| 5045 | 100 | 21 | 79 | STS/RPR Positive Units from the United States |
| 5040 | 65 | 65 | 0 | Negative Bulk Material - Serum @ 60mL's each |
| 5039 | 55 | 55 | 0 | HIV Positive Samples from Inventory |
| 4945 | 2 | 2 | 0 | HAV/Parvo IgM Positive SFE's for NAT Testing |
| 4944 | 15 | 15 | 0 | HIV Positive SFE's from Africa for CMV DNA Viremia Analysis |
| 4936 | 290 | 168 | 122 | Blood Collection Protocol form a Diverse Age Group of Healthy D/Ps (Donor/Participants) |
| 4927 | 20 | 20 | 0 | HIV Positive K3 EDTA Samples from Inventory |
| 4880 | 5 | 5 | 0 | HIV Positive Serum Samples from Inventory |
| 4879 | 210 | 210 | 0 | HIV Negative Bulk Samples from Inventory (CPD) |
| 4878 | 105 | 105 | 0 | HIV Positive K3 EDTA Samples from Inventory |
| 4852 | 11 | 11 | 0 | Pre-Selected HCV Genotyped Samples from Inventory |
| 4808 | 12 | 12 | 0 | Pre-Selected HCV Viral Load Samples from Inventory |
| 4796 | 10 | 3 | 7 | HAV IgM / Parovirus IgM Positive/Reactive Samples for Evaluation with Unit Back Ups |
| 4795 | 5 | 5 | 0 | HBsAg Positive Units from the United States |
| 4646 | 200 | 88 | 112 | Evaluation of the LightCycler® MRSA Advanced Test for Detection of Methicillin Resistant Staphylococcus aureus (MRSA) Directly From Nasal Swabs Compared With a Commercially Available Nucleic Acid Amplification Test and Culture |
| 4639 | 1000 | 962 | 38 | Chlamydia / Gonorrhea Positive Plasma Samples |
| 4626 | 9 | 9 | 0 | Pre-Selected HBV Vral Load Samples from Inventory |
| 4625 | 1 | 1 | 0 | Pre-selected HBsAg Serum Unit form Inventory |
| 4610 | 12 | 13 | -1 | HIV-1 Samples for Evaluation for the Production of Panel. |
| 4604 | 1 | 1 | 0 | Pre-Selected HIV-1 Unit from Inventory |
| 4594 | 5 | 5 | 0 | HIV-2 SFE's form Inventory |
| 4590 | 89 | 89 | 0 | Pre-Selcted HIV-1 Samples from Inventory |
| 4588 | 20 | 11 | 9 | Anti-HTLV I/II Positive Units for SFE |
| 4584 | 1 | 1 | 0 | Pre-Selected HBsAg Samples from Inventory |
| 4583 | 5 | 5 | 0 | HBsAg Serum Pre-Samples with Unit Back-Ups |
| 4582 | 100 | 30 | 70 | Anti-HBcore Positive Units for SFE |
| 4490 | 12 | 12 | 0 | HIV Positive D/Ps with Viral Load > 10,000 Copies/mL |
| 4489 | 1000 | 75 | 925 | Viral Positive Units from Guinea Bissau - West Africa (HIV, HCV and HBV) |
| 4470 | 440 | 440 | 0 | Normal Unique K3 EDTA Samples: Negative for: Anti-HIV 1/2, Anti-HCV, HIV/HCV NAT, HBsAg, and Syphilis. |
| 4460 | 8 | 8 | 0 | HAV Positive D/Ps |
| 4405 | 550 | 550 | 0 | Normal Unique K3 EDTA Samples: Negative for: Anti-HIV 1/2, Anti-HCV, HIV/HCV NAT, HBsAg, and Syphilis. |
| 4402 | 27 | 0 | 27 | Normal Group Blood Collection Protocol |
| 4401 | 30 | 0 | 30 | HIV Positive Group Blood Collection Protocol |
| 4387 | 10 | 10 | 0 | HIV-1 High Titer Plasma Samples |
| 4386 | 20 | 20 | 0 | HIV-1 Subtype AG Samples |
| 4385 | 47 | 46 | 1 | Pre-Selected HCV Samples from Inventory with Viral Load Determinations |
| 4377 | 101 | 101 | 0 | Normal Matched Set Collection |
| 4286 | 5 | 5 | 0 | Sodium Citrate Plasma Units |
| 4256 | 44 | 44 | 0 | Pre-Selected HCV Viral Load Samples form Inventory |
| 4186 | 65 | 38 | 27 | GT-HIV-175 - HIV Positive Sample Collection |
| 4156 | 100 | 57 | 43 | HIV Positive; > 50 Copies/mL Viral Load Pre-Screening Event - Part 2 |
| 4145 | 11 | 11 | 0 | Parvo/HAV IgG & IgM Negative Samples from Inventory |
| 4117 | 150 | 63 | 87 | HIV Positive; > 50 Copies/mL Viral Load Pre-Screening Event |
| 4114 | 125 | 56 | 69 | HIV Positive Sample Collection |
| 4098 | 50 | 39 | 11 | Pre-Selected HCV Positive Samples with Viral Load Testing |
| 4095 | 2 | 2 | 0 | Pre-Selected HIV Positive Samples |
| 3981 | 6 | 6 | 0 | Pre-Selected Samples from Inventory |
| 3980 | 10 | 10 | 0 | HIV-2 Units in Inventory |
| 3948 | 10 | 10 | 0 | HCV Positive D/Ps for the Evalutaion of different matrices and sample handling conditions in Viral Load detection. |
| 3934 | 1 | 1 | 0 | Toxo M SFE (Sample for Evaluation) |
| 3931 | 3 | 3 | 0 | HBV Naturally Ocurring Super Elevated Viral Load Samples |
| 3907 | 2 | 2 | 0 | HBV Samples for Evaluation |
| 3895 | 30 | 1 | 29 | HTLV I/II Positive D/Ps |
| 3890 | 8 | 8 | 0 | HIV-2 Samples |
| 3867 | 2 | 2 | 0 | 8 Liters of Sodium Citrate Plasma. Negative for HIV/HCV NAT, Anti-HIV 1/2, HBsAg, Anti-HCV, and RPR |
| 3866 | 32 | 32 | 0 | 8 Liters of K3 EDTA Normal Plasma: Negative for HIV/HCV NAT, Anti-HIV 1/2, HBsAg, Anti-HCV, and RPR |
| 3865 | 13 | 13 | 0 | HAV IgM and HIV-2 SFE's (Samples for Evaluation) |
| 3823 | 6 | 6 | 0 | CMV IgM Positive Samples from Inventory |
| 3822 | 6 | 6 | 0 | Pre-Selected Units from Pre-Samples |
| 3805 | 150 | 155 | -5 | HIV Negative Sample Collection |
| 3785 | 1 | 1 | 0 | High Titer HBsAg Sample for Evaluation |
| 3767 | 1000 | 1000 | 0 | Pre-Samples with Unit Back Ups: Normal, Serum or Plasma, 3mL, Less than or equal to -10°C. Age, Gender and Draw Date of Available |
| 3763 | 6 | 6 | 0 | Pre-Selected HCV Samples from Inventory |
| 3733 | 4 | 4 | 0 | Pre-Selected HIV-2 Units from Inventory |
| 3712 | 7 | 7 | 0 | HIV-2 Samples for Evaluation |
| 3701 | 110 | 15 | 95 | Syphilis Positive and Control Group Blood Collection Protocol HIV Positive D/Ps – Treponemal Confirmed |
| 3688 | 1 | 1 | 0 | Parvovirus B19 IgM Positive Serum Unit |
| 3679 | 2 | 2 | 0 | HAV IgM Positive Units |
| 3656 | 87 | 87 | 0 | Multiple Matrix HIV-1 Fresh Viral Load Stratified D/Ps |
| 3655 | 30 | 30 | 0 | Random, Plasma (No Heparin) Collected by Plasmapheresis |
| 3654 | 30 | 30 | 0 | Matched Sets: Donor Bag, Tubing Segment & Serum Sample -4mL's Plamsa from the Donor Bag (No Heparin) -4mL's of Plamsa form Tubing Segment of Donor Bag -Two (2) x 4mL's of Serum from Donor (Red Tops) |
| 3625 | 500 | 500 | 0 | Normal K3 EDTA Samples Negative for HIV/HCV NAT, Anti-HIV 1/2, Anti-HCV, HBsAg & RPR |
| 3603 | 475 | 571 | -96 | Parvovirus IgG & IgM / Hepatitis A IgG & IgM Negative Samples |
| 3602 | 12 | 12 | 0 | Normal K3 EDTA Plasma Units Negative/Non-Reactive for HIV/HCV NAT, Anti-HIV 1/2, HBsAg, Anti-HCV & Syphillis. |
| 3561 | 5 | 1 | 4 | Normal Plasmapherese Units |
| 3376 | 2 | 0 | 2 | Pre-Selected HIV-1 & Anti-HBcore Units from Inventory |
| 3317 | 19 | 19 | 0 | Pre-Selected HIV, HCV & HBsAg Samples from Inventory |
| 3309 | 22 | 22 | 0 | Pre-Selected Toxoplasma IgG Samples from Inventory |
| 2971 | 1 | 1 | 0 | HCV Genotype 1a |
| 2549 | 1000 | 1072 | -72 | Normal Serum/Plasma Samples with 150mL Back-Up Units. C of A to include: -Age -Gender -Ethnicity |
| 1666 | 100 | 240 | -140 | • HIV Positive D/Ps. • All D/Ps must be 18 years of age or older. • All D/Ps must be able to provide written informed consent. • All D/Ps must have had at least one of the following: o Anti‐HIV ½ Positive / Reactive test Result; o Western Blot Positive. • All D/Ps must have > 40 copies/mL Viral Load. • 50 D/Ps from the United States, stratified by matrix as follows: - 20 D/Ps in K2EDTA; - 10 D/Ps in ACD; - 20 D/Ps PPT. • 50 D/Ps from the European Union, stratified by matrix as follows: - 20 D/Ps in K2EDTA; - 10 D/Ps in ACD; - 20 D/Ps PPT. |
| 1558 | 1 | 1 | 0 | HCV Genotype 3a Sample from Inventory |
| 1488 | 25 | 25 | 0 | Chagas Positive Matched Sets (Serum & Plasma) |
| 1487 | 20 | 40 | -20 | Chagas Positive -Serum or Plasma -20 from Latin/South America |
| 1486 | 20 | 20 | 0 | Chagas Positive -Serum or Plasma -20 from Brazil |
| 1485 | 22 | 21 | 1 | Chagas Positive -Serum or Plasma -20 from Nicaragua |
| 1484 | 20 | 21 | -1 | Chagas Positive -Serum or Plasma -20 from Bolivia |
| 1336 | 1 | 1 | 0 | HCV Positive D/P Genotype 3A |
| 1331 | 20 | 0 | 20 | Chagas Positive -Serum or Plasma -20 from Colombia |
| 1113 | 4 | 4 | 0 | Pre-Selected HCV Genotyped and Viral Load D/Ps |
| 1040 | 43 | 43 | 0 | Pre-Selected HBV Acute Specimens from Inventory |
| 985 | 50 | 50 | 0 | Normal Sodium Citrate Samples Greater than or equal to 1mL |
| 984 | 100 | 100 | 0 | Normal Lithium Heparin Samples Greater than 1mL |
| 983 | 2 | 2 | 0 | Pre-Selected HCV Positive & Genotyped Specimens |
| 982 | 300 | 0 | 300 | Normal Serum Specimens (150 Male /150 Female) |
| 981 | 1 | 1 | 0 | Whole Blood Unit |
| 959 | 300 | 300 | 0 | Normal Plasma Lithium Heparin or Sodium Heparin |
| 946 | 20 | 0 | 20 | Geographically Diverse Samples - Australia |
| 945 | 20 | 20 | 0 | Geographically Diverse Samples - Guinea-Bissau |
| 944 | 20 | 0 | 20 | Geographically Diverse Samples - Argentina |
| 943 | 40 | 20 | 20 | Geographically Diverse Samples - US (20 East Coast / 10 West Coast) |
| 942 | 20 | 0 | 20 | Geographically Diverse Samples - Japan |
| 941 | 100 | 100 | 0 | Cross-Reactive Samples - Unlinked IVD User |
| 940 | 12 | 0 | 12 | Cross-Reactive Samples Post-Influ Vaccine Specimens |
| 939 | 12 | 0 | 12 | Cross-Reactive Samples Pre-Influ Vaccine Specimens |
| 938 | 6 | 5 | 1 | Cross-Reactive Samples - ANA (Anti-Nuclear Antibody) Specimens |
| 937 | 20 | 20 | 0 | HIV-1 Western Blot Specimens |
| 934 | 1700 | 1700 | 0 | Random Serum Specimens |
| 930 | 25 | 28 | -3 | Normal Matched Paired Sets- (Lithium Heparin, K2 EDTA & Sodium Citrate Plasma) |
| 906 | 240 | 240 | 0 | 120 Normal Serum Specimens 120 Normal Plasma Specimens |
| 894 | 2550 | 940 | 1610 | Random Serum Specimens |
| 893 | 1000 | 741 | 259 | 500 Serum and 500 Plasma Samples |
| 892 | 30 | 30 | 0 | Matched Paired Sets Plasma -Segmented Tubing & Serum Specimen |
| 889 | 10 | 10 | 0 | West Nile Virus Specimens |
| 888 | 20 | 20 | 0 | ANA Positive Specimens |
| 887 | 30 | 30 | 0 | Plasmapherese Units |
| 861 | 1500 | 324 | 1176 | Randon K2 EDTA Plasma Specimens |
| 860 | 1500 | 1015 | 485 | Random Serum Specimens |
| 854 | 120 | 120 | 0 | Matched Set -Plasma Bag -Segmented Tubing -Serum Specimen |
| 853 | 24 | 18 | 6 | HCV-infected plasma samples, aliquoted into 1mL vials. |
| 784 | 22 | 22 | 0 | Random Serum Specimens |
| 783 | 164 | 164 | 0 | Random Serum Specimens |
| 741 | 2449 | 2449 | 0 | Random Serum Specimens |
| 730 | 49 | 49 | 0 | Selected HBsAg Samples from Inventory |
| 712 | 5 | 3 | 2 | Pre-Selected Chronic HBV D/Ps |
| 710 | 50 | 49 | 1 | Random Serum Specimens |
| 709 | 230 | 230 | 0 | Random Serum Specimens |
| 701 | 140 | 99 | 41 | HIV-2 Samples |
| 644 | 20 | 20 | 0 | Chagas Positive -Serum or Plasma -20 from Bolivia |
| 578 | 1250 | 0 | 1250 | Normal Health Population Prospective Blood Collection Protocol |
| 577 | 33 | 33 | 0 | HBsAg Pre-Selected Samples |
| 543 | 200 | 199 | 1 | HIV Positive Samples |
| 498 | 1 | 1 | 0 | Pre-Selected D/P |
| 489 | 4 | 4 | 0 | HCV Genotype 1b Specimens |
| 488 | 2 | 0 | 2 | Pre-Selected HCVs for Genotype and Titer |
| 484 | 55 | 52 | 3 | Plasmapherese Samples 3-5mL's |
| 468 | 200 | 200 | 0 | Serum Samples - Normal |
| 453 | 5 | 5 | 0 | Elevated HIV Viral Load D/Ps |
| 445 | 1500 | 1500 | 0 | Plasmapherese Samples 3-5mL's |
| 438 | 6 | 4 | 2 | Pre-Selected HCVs for Genotype and Titer based on Geographic Region of Residence |
| 436 | 30 | 30 | 0 | Plasmapherese Units |
| 407 | 30 | 30 | 0 | Pre-Selected HCV Plasma Inventory Specimens |
| 401 | 48 | 0 | 48 | Proficiency Testing Program Panel Members |
| 394 | 100 | 0 | 100 | Specific Range Serum Chloride Specimens |
| 393 | 100 | 0 | 100 | Specific Range Serum Potassium Specimens |
| 392 | 100 | 0 | 100 | Specific Range Serum Sodium Specimens |
| 391 | 100 | 0 | 100 | Elevated Total Protein Samples |
| 390 | 100 | 0 | 100 | Elevated Triglyceride Samples |
| 388 | 100 | 0 | 100 | Total / Direct Bilirubin Elevated Samples |
| 380 | 50 | 3 | 47 | HTLV I/II Samples for Evaluation |
| 361 | 25 | 25 | 0 | Matrix Normal D/Ps |
| 359 | 46 | 46 | 0 | Pre-Selected HBsAg Postive Smaples |
| 358 | 1 | 1 | 0 | Plasmapherese Samples for Evaluation |
| 355 | 20 | 20 | 0 | Anti-HAV Serum Specimens |
| 351 | 10 | 10 | 0 | HTLV Linked; Collected under IRB with IC |
| 335 | 10 | 10 | 0 | HTLV Linked; Collected under IRB with IC |
| 308 | 11 | 11 | 0 | HIV-2 Selection of Samples |
| 306 | 140 | 12 | 128 | HIV-2 positive Specimens |
| 303 | 39 | 39 | 0 | HBsAg Selected Samples from Inventory |
| 290 | 140 | 138 | 2 | HIV-2 samples |
| 277 | 1 | 1 | 0 | Normal D/P |
| 274 | 20 | 20 | 0 | HIV-2 Specimens |
| 273 | 1 | 1 | 0 | HIV Viral Load Specific D/P |
| 272 | 1000 | 138 | 862 | HIV-1 / HIV-2 Samples from Guinea Bissau |
| 268 | 30 | 28 | 2 | HBsAg Subtype ay |
| 262 | 6 | 6 | 0 | HCV Genotype & Titered Pre-Selected D/Ps |
| 260 | 50 | 36 | 14 | HAV IgM Positive Specimens |
| 257 | 15 | 14 | 1 | Post HAV Vaccination D/P's |
| 256 | 1 | 1 | 0 | Normal D/P - Non-Infectious |
| 254 | 3 | 3 | 0 | HCV Genotype 3 & 4 in stock |
| 250 | 50 | 0 | 50 | HIV Positive D/P's with Specific WB Band Patterns |
| 249 | 50 | 0 | 50 | Oral Fluid Samples from Specific HIV WB band pattern D/P's |
| 248 | 1 | 1 | 0 | Normal D/P |
| 246 | 10 | 0 | 10 | HBsAg Positive Plasma Units (ay Subtype) |
| 243 | 6 | 6 | 0 | Rubella IgM Positive Samples |
| 242 | 2 | 2 | 0 | HBsAg (ad) - Samples for Evaluation |
| 240 | 6 | 6 | 0 | HBsAg (ad) - Samples for Evaluation |
| 238 | 700 | 436 | 264 | HIV , HCV & HBV single infection D/P's |
| 235 | 2 | 2 | 0 | Selected HIV-2 Units |
| 226 | 1 | 1 | 0 | HIV-2 Sample for Evaluation |
| 222 | 8 | 0 | 8 | Paired Collection |
| 221 | 200 | 182 | 18 | Chagas Positive samples from Mexico |
| 220 | 39 | 15 | 24 | Pre-Selected HIV Positive D/P's (Group M) |
| 219 | 10 | 6 | 4 | HIV Special Container Blood Collection Protocol |
| 210 | 5 | 5 | 0 | HCV Positive Specimens |
| 209 | 2 | 2 | 0 | Pre-Selected D/P's - Syphilis Positive |
| 208 | 1 | 1 | 0 | HCV Positive Samples |
| 207 | 3 | 3 | 0 | HIV Positive D/P's with Phenosense GT Information |
| 203 | 4 | 4 | 0 | HIV & HCV Special Container Blood Collection Protocol |
| 202 | 40 | 25 | 15 | HCV Specimens |
| 200 | 350 | 172 | 178 | HCV High Risk - IV Drug Users |
| 199 | 21 | 21 | 0 | Total Protein Specimens with a Value Greater Than 9 g/dL |
| 198 | 10 | 2 | 8 | HIV-2 Samples for Evaluation |
| 195 | 1 | 1 | 0 | HIV-2 Sample of Evaluation |
| 194 | 10 | 10 | 0 | HIV-2 Pre-Seleced Specimens |
| 192 | 1 | 1 | 0 | Pre-Selected HIV-2 Specimen |
| 191 | 12 | 13 | -1 | HAV IgG Positive & ALT > 108 samples |
| 190 | 750 | 867 | -117 | Generalized Hepatitis High Risk Population |
| 189 | 1 | 1 | 0 | HCV Genotype 4 Sample for Evaluation |
| 187 | 1000 | 0 | 1000 | Chagas Positive Specimens in Inventory |
| 186 | 3 | 3 | 0 | HIV SFE's from Units (HIV Naive) |
| 185 | 3 | 3 | 0 | Pre-Designated HIV Chosen Samples |
| 184 | 100 | 0 | 100 | Negative Specimens (Plasma) |
| 183 | 100 | 0 | 100 | Negative Specimens (Serum) |
| 182 | 60 | 0 | 60 | Tigris DTS System Clinical Equivalence Study for the APTIMA CT Assay and APTIMA GC Assay (Female D/Ps) |
| 181 | 1 | 1 | 0 | HIV-2 Sample for Evaluation |
| 180 | 60 | 0 | 60 | Tigris DTS System Clinical Equivalence Study for the APTIMA CT Assay and APTIMA GC Assay (Male D/Ps) |
| 179 | 1 | 1 | 0 | HIV-2 Unit Collection (West Africa) |
| 178 | 1000 | 758 | 242 | Hepatitis High Risk Population Blood Collection Protocol |
| 177 | 15 | 7 | 8 | HIV Known Viral Load D/Ps |
| 176 | 100 | 66 | 34 | Non-Liver Disease D/P's |
| 175 | 10 | 10 | 0 | Hepatitis B Vaccine Recipients |
| 172 | 4 | 4 | 0 | H. Pylori IgA Positive, IgG Negative |
| 170 | 10 | 12 | -2 | Multiparous Women |
| 169 | 50 | 16 | 34 | Rubella IgG Negative, Toxo IgM Positive & Rubella IgM Positive Specimens |
| 166 | 15 | 3 | 12 | HIV Naive Positive Specimens & Units |
| 165 | 100 | 91 | 9 | Mutiple Disease State D/P's |
| 163 | 1 | 1 | 0 | Rubella-M |
| 162 | 497 | 497 | 0 | Chagas Specimens from Brazil |
| 161 | 100 | 18 | 82 | HAV Vaccine Recipient Study |
| 160 | 3 | 3 | 0 | Pre-selected HTLV Samples |
| 159 | 30 | 12 | 18 | HIV Positive Units |
| 158 | 5 | 5 | 0 | scl-70- Samples for Evaluation |
| 157 | 11 | 4 | 7 | HCV Positive Samples for Evaluation |
| 156 | 1 | 1 | 0 | Rubella IgM Positive Samples for Evaluation |
| 155 | 1 | 1 | 0 | Rubella IgM Plasmapherese Units |
| 154 | 5 | 4 | 1 | HTLV Samples for Evaluation |
| 153 | 200 | 201 | -1 | Chagas Postive Archived Specimens |
| 152 | 20 | 14 | 6 | HIV-2 Matrix Study |
| 151 | 3 | 3 | 0 | HIV Panel Members |
| 147 | 2 | 1 | 1 | Rubella & Toxo M Samples for Evaluation |
| 146 | 31 | 31 | 0 | Hepatitis B Vaccinated D/P's (Matched Sets) |
| 144 | 50 | 2 | 48 | HBV Chronic / Recovered D/P's |
| 141 | 1 | 1 | 0 | HIV-2 Sample for Evaluation |
| 138 | 8 | 8 | 0 | Toxo IgM and Rubella IgM Positive |
| 137 | 61 | 41 | 20 | CMV IgM and other Sample sfor Ealuation |
| 136 | 1 | 1 | 0 | HCV Sample for Evaluation |
| 135 | 33 | 33 | 0 | HCV K3EDTA Plasma Specimens |
| 134 | 1 | 1 | 0 | HCV Genotype 4 SFE |
| 133 | 16 | 9 | 7 | Non Treated Hypothyroidism D/P's Non Treated Hyperthyroidism D/P's Contact BCW for additional details |
| 131 | 600 | 401 | 199 | A Point In Time Blood Collection Protocol in order to build a Repository of Specimens of D/P's at a High Risk or having Signs and Symptoms of Hepatitis |
| 130 | 1 | 1 | 0 | Pre-Identified HCV Genotype 4 D/P |
| 129 | 1 | 1 | 0 | HIV-2 Sample for Evaluation |
| 126 | 2 | 2 | 0 | Toxo and CMV IgM Units |
| 125 | 2 | 3 | -1 | HIV + D/P's Greater than 40K Copies/mL Viral Load |
| 124 | 50 | 0 | 50 | HIV Specimens |
| 123 | 15 | 15 | 0 | HIV Positive D/P's with Detectable Viral Loads |
| 122 | 500 | 337 | 163 | Psoriasis Blood Collection Protocol |
| 121 | 1 | 1 | 0 | HCV Genotype 4 Source Plasma |
| 120 | 10 | 7 | 3 | CMV, Rubella and Toxoplasmosis IgG/IgM Samples for Evaluation |
| 119 | 20 | 20 | 0 | HIV Plasma Specimens |
| 117 | 30 | 8 | 22 | Cardiolipin IgG & IgM Matched Sets |
| 116 | 60 | 32 | 28 | Chagas Positive Specimens form Mexico and Brazil |
| 115 | 1 | 1 | 0 | HIV-2 Positive Unit |
| 114 | 10 | 10 | 0 | HAV Vaccine Post-Bleeds |
| 111 | 50 | 56 | -6 | Rf Positive Specimens |
| 110 | 15 | 13 | 2 | Intrinsic Factor Antibody Positive D/P's Pernicious Anemia Diagnosed D/P's |
| 103 | 10 | 1 | 9 | A Point in Time Blood and Saliva Collection Protocol in order to build a Repository of a diverse group of Gynecological Diseases - Adenomyosis |
| 102 | 10 | 6 | 4 | A Point in Time Blood Collection Protocol in order to build a Repository of a diverse group of Gynecological Diseases - Uterine Fibroids |
| 101 | 10 | 1 | 9 | A Point in Time Blood and Saliva Collection Protocol in order to build a Repository of a diverse group of Gynecological Diseases - Pelvic Inflammatory Disease |
| 95 | 10 | 5 | 5 | A Point in Time Blood and Saliva Collection Protocol in order to build a Repository of a diverse group of Gynecological Diseases - Endometriosis |
| 90 | 5 | 5 | 0 | Intrinsic Factor Antibody Positive D/P's Pernicious Anemia Diagnosed D/P's |
| 84 | 200 | 163 | 37 | HIV Positive D/P's Known Viral Load > 2000 |
| 82 | 150 | 112 | 38 | HIV Type 2 Positive D/P's |
| 76 | 500 | 166 | 334 | Acute (Recently Diagnosed) HBsAg Positive D/P's |
| 74 | 300 | 63 | 237 | Lupus D/P's (SLE Positive) |
| 71 | 2 | 1 | 1 | HIV Positive D/P's with a Viral Load between 5,000 and 10,000 copies/mL |
| 61 | 10 | 6 | 4 | HIV Positive D/P's with Phenotypical & Genotypical Data. Viral Load must be Greater than 40,000 copies/mL |
| 47 | 10 | 0 | 10 | Lupus D/P's (SLE Positive) |
| 28 | 200 | 75 | 125 | HCV Positive D/P's |
| 15 | 1200 | 1271 | -71 | D/P's > 45 Years of Age No History of Diabetes nor Heart Disease |
